Suboccipital Inhibition in Tension Headache

Not Applicable

• Conditions: Tension Headache
• Interventions: Other: Suboccipital inhibition in tension headache

• Registration Number: NCT04376125
• Lead Sponsor: Universidad de León

Brief Summary

The researchers will carry out a randomized experimental study. Participants in the experimental group will receive a treatment based on suboccipital inhibition technique in addition to conventional treatment. Participants in the control group will only receive the conventional treatment. The existence of significant differences in both groups will be analyzed.

Detailed Description

Conventional therapy will consist of microwaves, interference currents, and manual therapy.

Study Timeline

• Study Start: 2019-02-01
• Study First Submitted: 2019-02-24
• Primary Completion: 2019-11-22
• Status Verified: 2020-05
• Study First Submitted QC: 2020-05-01
• Last Update Submitted: 2020-05-01
• Study First Posted: 2020-05-06
• Last Update Posted: 2020-05-06
• Study Completion: 2020-06-30

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• pathology tension headache associated with cervicalgia

Exclusion Criteria

• pathology of nervous system

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
study of results	Suboccipital inhibition in tension headache	We compared data from both groups
Suboccipital inhibition in tension headache	Suboccipital inhibition in tension headache	Two groups of patients suffering from tension headache associated with cervicalgia are selected. The control group performs conventional therapy. The experimental group performs conventional therapy plus the technique of suboccipital inhibition

Primary Outcome Measures

Name	Time	Method
Change in Visual Analogue Scale for Pain	immediately before starting the intervention and after the last session of the intervention, that is, 2 weeks from the start	a continuous scale comprised of a horizontal (HVAS) or vertical (VVAS) line, usually 10 centimeters (100 mm) in length, anchored by 2 verbal descriptors, one for each symptom extreme: "no pain" (score of 0) and "worst imaginable pain" (score of 10)

Secondary Outcome Measures

Name	Time	Method
Change in Six-item Headache Impact Text	immediately before starting the intervention and after the last session of the intervention, that is, 2 weeks from the start	A global measure of adverse headache impact. The final HIT-6 score is obtained from simple summation of the six items and ranges between 36 and 78, with larger scores reflecting greater impact.

Trial Locations

Locations (1)

Cristina Blanco Ortega; 🇪🇸 León, Spain